| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Residence Characteristics | 17 | 2020 | 181 | 5.190 |
Why?
|
| Marijuana Smoking | 16 | 2020 | 37 | 4.990 |
Why?
|
| Urban Population | 11 | 2019 | 79 | 3.840 |
Why?
|
| Alcohol Drinking | 23 | 2022 | 244 | 3.710 |
Why?
|
| African Americans | 15 | 2022 | 1373 | 3.370 |
Why?
|
| Adolescent | 69 | 2022 | 3254 | 2.560 |
Why?
|
| Adolescent Behavior | 10 | 2020 | 57 | 2.350 |
Why?
|
| Young Adult | 55 | 2022 | 2402 | 2.300 |
Why?
|
| Risk-Taking | 9 | 2019 | 91 | 2.120 |
Why?
|
| Emigrants and Immigrants | 7 | 2020 | 235 | 1.990 |
Why?
|
| Students | 18 | 2018 | 168 | 1.770 |
Why?
|
| Smoking | 16 | 2022 | 427 | 1.650 |
Why?
|
| Male | 94 | 2022 | 17807 | 1.620 |
Why?
|
| Female | 96 | 2022 | 18164 | 1.590 |
Why?
|
| Humans | 113 | 2022 | 29093 | 1.410 |
Why?
|
| Marijuana Abuse | 6 | 2019 | 18 | 1.400 |
Why?
|
| Poverty | 7 | 2019 | 99 | 1.390 |
Why?
|
| Universities | 19 | 2018 | 142 | 1.380 |
Why?
|
| Cannabis | 4 | 2022 | 18 | 1.350 |
Why?
|
| HIV Infections | 6 | 2021 | 335 | 1.330 |
Why?
|
| Hispanic Americans | 10 | 2019 | 904 | 1.280 |
Why?
|
| Social Environment | 6 | 2019 | 75 | 1.280 |
Why?
|
| Alcohol-Related Disorders | 5 | 2021 | 22 | 1.230 |
Why?
|
| Alcoholism | 6 | 2021 | 95 | 1.200 |
Why?
|
| Adult | 54 | 2022 | 8420 | 1.190 |
Why?
|
| Alcoholic Intoxication | 5 | 2014 | 31 | 1.160 |
Why?
|
| Diabetes Mellitus, Type 1 | 7 | 2022 | 180 | 1.130 |
Why?
|
| Tobacco Use Disorder | 4 | 2021 | 76 | 1.060 |
Why?
|
| Longitudinal Studies | 17 | 2019 | 720 | 1.010 |
Why?
|
| Child | 24 | 2022 | 2219 | 0.930 |
Why?
|
| United States | 28 | 2022 | 3630 | 0.930 |
Why?
|
| Opioid-Related Disorders | 2 | 2022 | 50 | 0.910 |
Why?
|
| Baltimore | 8 | 2016 | 49 | 0.810 |
Why?
|
| Risk Factors | 23 | 2022 | 3531 | 0.800 |
Why?
|
| Mood Disorders | 3 | 2018 | 19 | 0.790 |
Why?
|
| Product Labeling | 4 | 2021 | 12 | 0.750 |
Why?
|
| Cluster Analysis | 6 | 2016 | 128 | 0.740 |
Why?
|
| Minority Groups | 3 | 2019 | 69 | 0.740 |
Why?
|
| Preventive Health Services | 1 | 2020 | 30 | 0.740 |
Why?
|
| Multifactorial Inheritance | 2 | 2020 | 19 | 0.730 |
Why?
|
| Cross-Sectional Studies | 18 | 2020 | 1356 | 0.720 |
Why?
|
| Mental Disorders | 5 | 2014 | 103 | 0.700 |
Why?
|
| Social Problems | 1 | 2019 | 2 | 0.700 |
Why?
|
| Social Support | 3 | 2019 | 163 | 0.690 |
Why?
|
| Depression | 6 | 2016 | 380 | 0.670 |
Why?
|
| Cocaine | 4 | 2012 | 264 | 0.670 |
Why?
|
| North Carolina | 26 | 2020 | 1423 | 0.660 |
Why?
|
| European Continental Ancestry Group | 4 | 2018 | 1131 | 0.650 |
Why?
|
| Substance-Related Disorders | 5 | 2018 | 113 | 0.630 |
Why?
|
| Logistic Models | 12 | 2019 | 727 | 0.600 |
Why?
|
| Cohort Studies | 9 | 2021 | 1687 | 0.590 |
Why?
|
| Peer Group | 5 | 2020 | 41 | 0.580 |
Why?
|
| Homosexuality, Male | 3 | 2019 | 73 | 0.580 |
Why?
|
| Mothers | 4 | 2018 | 79 | 0.580 |
Why?
|
| Mass Screening | 4 | 2019 | 223 | 0.550 |
Why?
|
| Age Factors | 10 | 2016 | 1108 | 0.540 |
Why?
|
| Social Behavior | 4 | 2019 | 67 | 0.540 |
Why?
|
| Mammography | 5 | 2006 | 37 | 0.520 |
Why?
|
| Breast | 4 | 2005 | 53 | 0.450 |
Why?
|
| Sexually Transmitted Diseases | 2 | 2015 | 37 | 0.440 |
Why?
|
| Receptors, Dopamine | 1 | 2012 | 20 | 0.430 |
Why?
|
| Social Dominance | 1 | 2012 | 18 | 0.430 |
Why?
|
| Putamen | 1 | 2012 | 25 | 0.430 |
Why?
|
| Caudate Nucleus | 1 | 2012 | 23 | 0.420 |
Why?
|
| Program Development | 1 | 2012 | 85 | 0.410 |
Why?
|
| Prevalence | 10 | 2019 | 896 | 0.410 |
Why?
|
| Censuses | 1 | 2011 | 6 | 0.400 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2012 | 96 | 0.400 |
Why?
|
| Educational Status | 6 | 2018 | 164 | 0.390 |
Why?
|
| Comorbidity | 7 | 2019 | 540 | 0.390 |
Why?
|
| Postmenopause | 6 | 2006 | 397 | 0.390 |
Why?
|
| Tobacco | 3 | 2021 | 50 | 0.380 |
Why?
|
| Socioeconomic Factors | 6 | 2019 | 391 | 0.370 |
Why?
|
| Blood Glucose | 4 | 2022 | 466 | 0.370 |
Why?
|
| Sexual Behavior | 5 | 2019 | 97 | 0.370 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2019 | 326 | 0.350 |
Why?
|
| Sex Factors | 5 | 2016 | 631 | 0.340 |
Why?
|
| Virginia | 10 | 2018 | 64 | 0.340 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2006 | 28 | 0.340 |
Why?
|
| Middle Aged | 21 | 2020 | 10829 | 0.330 |
Why?
|
| Diabetes Complications | 2 | 2019 | 171 | 0.330 |
Why?
|
| Insulin | 2 | 2022 | 346 | 0.330 |
Why?
|
| Commerce | 3 | 2020 | 37 | 0.320 |
Why?
|
| Genome-Wide Association Study | 2 | 2020 | 543 | 0.300 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2006 | 14 | 0.290 |
Why?
|
| Models, Statistical | 5 | 2015 | 163 | 0.290 |
Why?
|
| Staphylococcal Infections | 5 | 2007 | 57 | 0.280 |
Why?
|
| Minors | 1 | 2005 | 1 | 0.280 |
Why?
|
| Stress, Psychological | 2 | 2018 | 208 | 0.280 |
Why?
|
| Marketing | 2 | 2018 | 24 | 0.280 |
Why?
|
| Staphylococcus aureus | 4 | 2007 | 45 | 0.270 |
Why?
|
| Legislation, Drug | 2 | 2019 | 7 | 0.270 |
Why?
|
| African Continental Ancestry Group | 1 | 2007 | 350 | 0.270 |
Why?
|
| Cocaine-Related Disorders | 2 | 2007 | 106 | 0.270 |
Why?
|
| Models, Theoretical | 1 | 2006 | 126 | 0.270 |
Why?
|
| Unsafe Sex | 2 | 2017 | 23 | 0.260 |
Why?
|
| Focus Groups | 3 | 2021 | 103 | 0.260 |
Why?
|
| Parents | 2 | 2019 | 120 | 0.260 |
Why?
|
| Health Promotion | 3 | 2017 | 220 | 0.260 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 3 | 2012 | 28 | 0.250 |
Why?
|
| Age of Onset | 3 | 2018 | 95 | 0.250 |
Why?
|
| Suicide, Attempted | 4 | 2009 | 29 | 0.250 |
Why?
|
| Odds Ratio | 3 | 2021 | 447 | 0.240 |
Why?
|
| Carrier State | 5 | 2007 | 20 | 0.240 |
Why?
|
| Health Surveys | 4 | 2019 | 191 | 0.240 |
Why?
|
| Depressive Disorder | 3 | 2017 | 74 | 0.240 |
Why?
|
| Self Concept | 2 | 2013 | 41 | 0.230 |
Why?
|
| Air Microbiology | 4 | 2007 | 16 | 0.220 |
Why?
|
| Prospective Studies | 8 | 2018 | 2019 | 0.220 |
Why?
|
| Dyslexia | 3 | 2007 | 8 | 0.220 |
Why?
|
| Hallucinogens | 1 | 2022 | 11 | 0.210 |
Why?
|
| Diabetic Ketoacidosis | 2 | 2019 | 9 | 0.210 |
Why?
|
| Factor Analysis, Statistical | 4 | 2019 | 70 | 0.210 |
Why?
|
| Sexual Partners | 2 | 2019 | 33 | 0.210 |
Why?
|
| Estrogen Replacement Therapy | 5 | 2006 | 182 | 0.200 |
Why?
|
| Analgesics, Opioid | 2 | 2022 | 239 | 0.200 |
Why?
|
| Estrogens, Conjugated (USP) | 4 | 2006 | 125 | 0.200 |
Why?
|
| Anti-HIV Agents | 1 | 2021 | 50 | 0.200 |
Why?
|
| Employment | 3 | 2016 | 49 | 0.190 |
Why?
|
| Heroin | 1 | 2020 | 14 | 0.190 |
Why?
|
| Geography | 2 | 2011 | 34 | 0.190 |
Why?
|
| Data Collection | 5 | 2013 | 163 | 0.180 |
Why?
|
| Infant Behavior | 2 | 2016 | 8 | 0.180 |
Why?
|
| Health Status | 2 | 2020 | 368 | 0.180 |
Why?
|
| Common Cold | 4 | 2007 | 11 | 0.180 |
Why?
|
| Motivation | 1 | 2020 | 102 | 0.180 |
Why?
|
| Sex Education | 1 | 2019 | 3 | 0.170 |
Why?
|
| Perception | 1 | 2019 | 92 | 0.170 |
Why?
|
| Interviews as Topic | 3 | 2015 | 249 | 0.170 |
Why?
|
| Adipose Tissue | 1 | 2022 | 327 | 0.170 |
Why?
|
| Ethnic Groups | 3 | 2019 | 440 | 0.170 |
Why?
|
| Product Packaging | 1 | 2018 | 3 | 0.170 |
Why?
|
| Community-Based Participatory Research | 3 | 2017 | 105 | 0.170 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2018 | 18 | 0.170 |
Why?
|
| Women, Working | 1 | 2018 | 12 | 0.170 |
Why?
|
| Smoking Cessation | 3 | 2015 | 118 | 0.160 |
Why?
|
| Registries | 1 | 2019 | 278 | 0.160 |
Why?
|
| Breast Feeding | 1 | 2018 | 39 | 0.160 |
Why?
|
| Nasal Mucosa | 4 | 2006 | 19 | 0.160 |
Why?
|
| Body Weight | 1 | 2019 | 290 | 0.160 |
Why?
|
| Data Interpretation, Statistical | 3 | 2007 | 103 | 0.160 |
Why?
|
| Health Services Accessibility | 2 | 2014 | 231 | 0.150 |
Why?
|
| Self Efficacy | 2 | 2018 | 70 | 0.150 |
Why?
|
| Medroxyprogesterone Acetate | 4 | 2006 | 89 | 0.150 |
Why?
|
| Adiposity | 1 | 2018 | 191 | 0.150 |
Why?
|
| Condoms | 1 | 2017 | 35 | 0.150 |
Why?
|
| Genotype | 1 | 2019 | 735 | 0.150 |
Why?
|
| Social Facilitation | 2 | 2007 | 2 | 0.150 |
Why?
|
| Progesterone | 3 | 2005 | 80 | 0.150 |
Why?
|
| Psychometrics | 2 | 2016 | 129 | 0.140 |
Why?
|
| Parent-Child Relations | 1 | 2016 | 38 | 0.140 |
Why?
|
| Urban Health | 1 | 2016 | 14 | 0.140 |
Why?
|
| Violence | 1 | 2016 | 14 | 0.140 |
Why?
|
| Tobacco, Smokeless | 1 | 2015 | 12 | 0.140 |
Why?
|
| Sexuality | 1 | 2015 | 9 | 0.130 |
Why?
|
| Follow-Up Studies | 8 | 2019 | 2108 | 0.130 |
Why?
|
| Health Education | 1 | 2016 | 121 | 0.130 |
Why?
|
| Student Health Services | 1 | 2014 | 9 | 0.130 |
Why?
|
| Health Services | 1 | 2015 | 35 | 0.130 |
Why?
|
| Law Enforcement | 1 | 2015 | 26 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2012 | 641 | 0.130 |
Why?
|
| Bone Density | 2 | 2006 | 182 | 0.120 |
Why?
|
| Counseling | 1 | 2014 | 85 | 0.120 |
Why?
|
| Rural Population | 2 | 2014 | 246 | 0.120 |
Why?
|
| Life Change Events | 2 | 2021 | 21 | 0.120 |
Why?
|
| Health Personnel | 1 | 2015 | 111 | 0.120 |
Why?
|
| Self Administration | 2 | 2012 | 296 | 0.110 |
Why?
|
| Crime | 1 | 2012 | 4 | 0.110 |
Why?
|
| Child Abuse | 1 | 2013 | 26 | 0.110 |
Why?
|
| Friends | 1 | 2012 | 8 | 0.110 |
Why?
|
| Automobile Driving | 1 | 2012 | 24 | 0.110 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2014 | 154 | 0.110 |
Why?
|
| Analysis of Variance | 2 | 2012 | 454 | 0.110 |
Why?
|
| Homovanillic Acid | 1 | 2012 | 11 | 0.110 |
Why?
|
| Drug Prescriptions | 1 | 2012 | 52 | 0.110 |
Why?
|
| Menstrual Cycle | 1 | 2012 | 36 | 0.110 |
Why?
|
| Inflammation | 2 | 2006 | 507 | 0.110 |
Why?
|
| Community Health Services | 1 | 2012 | 54 | 0.100 |
Why?
|
| Central Nervous System Stimulants | 1 | 2012 | 74 | 0.100 |
Why?
|
| Health Services Needs and Demand | 1 | 2012 | 66 | 0.100 |
Why?
|
| Restaurants | 1 | 2011 | 7 | 0.100 |
Why?
|
| Risk Reduction Behavior | 1 | 2012 | 116 | 0.100 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 172 | 0.100 |
Why?
|
| Macaca fascicularis | 1 | 2012 | 389 | 0.100 |
Why?
|
| C-Reactive Protein | 3 | 2006 | 232 | 0.100 |
Why?
|
| Pilot Projects | 1 | 2012 | 469 | 0.090 |
Why?
|
| Central Nervous System Depressants | 1 | 2011 | 63 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2019 | 1379 | 0.090 |
Why?
|
| Protective Clothing | 2 | 2007 | 26 | 0.090 |
Why?
|
| Attention | 2 | 2021 | 83 | 0.090 |
Why?
|
| Population | 1 | 2009 | 8 | 0.090 |
Why?
|
| Databases, Factual | 1 | 2011 | 332 | 0.090 |
Why?
|
| Quality of Life | 3 | 2019 | 816 | 0.090 |
Why?
|
| Anxiety Disorders | 2 | 2007 | 60 | 0.090 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2006 | 31 | 0.080 |
Why?
|
| Family | 1 | 2009 | 105 | 0.080 |
Why?
|
| Child Development | 1 | 2009 | 35 | 0.080 |
Why?
|
| Family Characteristics | 1 | 2009 | 32 | 0.080 |
Why?
|
| Ethanol | 1 | 2011 | 185 | 0.080 |
Why?
|
| Reproducibility of Results | 5 | 2016 | 726 | 0.080 |
Why?
|
| Rhinovirus | 2 | 2005 | 9 | 0.080 |
Why?
|
| Estrone | 2 | 2006 | 7 | 0.080 |
Why?
|
| Child, Preschool | 3 | 2019 | 1167 | 0.080 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2005 | 92 | 0.080 |
Why?
|
| Internet | 3 | 2015 | 156 | 0.080 |
Why?
|
| Breast Neoplasms | 2 | 2005 | 666 | 0.080 |
Why?
|
| Sample Size | 1 | 2007 | 37 | 0.080 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 1 | 2007 | 1 | 0.080 |
Why?
|
| Psychosocial Deprivation | 1 | 2007 | 4 | 0.080 |
Why?
|
| Social Identification | 1 | 2007 | 9 | 0.080 |
Why?
|
| Fluorenes | 1 | 2007 | 3 | 0.080 |
Why?
|
| Parenting | 1 | 2007 | 19 | 0.080 |
Why?
|
| Aggression | 1 | 2007 | 29 | 0.080 |
Why?
|
| Phobic Disorders | 1 | 2007 | 8 | 0.070 |
Why?
|
| Discrimination Learning | 1 | 2007 | 20 | 0.070 |
Why?
|
| Dopamine Agonists | 1 | 2007 | 28 | 0.070 |
Why?
|
| Dopamine Antagonists | 1 | 2007 | 23 | 0.070 |
Why?
|
| Student Dropouts | 1 | 2006 | 5 | 0.070 |
Why?
|
| Monte Carlo Method | 1 | 2006 | 18 | 0.070 |
Why?
|
| Schizophrenia | 1 | 2007 | 38 | 0.070 |
Why?
|
| Piperazines | 1 | 2007 | 56 | 0.070 |
Why?
|
| Reinforcement Schedule | 1 | 2007 | 60 | 0.070 |
Why?
|
| Medically Underserved Area | 1 | 2006 | 22 | 0.070 |
Why?
|
| Vulnerable Populations | 1 | 2006 | 25 | 0.070 |
Why?
|
| Receptors, Dopamine D3 | 1 | 2007 | 33 | 0.070 |
Why?
|
| Disease Transmission, Infectious | 1 | 2006 | 14 | 0.070 |
Why?
|
| Problem-Based Learning | 1 | 2006 | 26 | 0.070 |
Why?
|
| Statistics as Topic | 1 | 2006 | 106 | 0.070 |
Why?
|
| Time Factors | 4 | 2018 | 2001 | 0.070 |
Why?
|
| Conditioning, Operant | 1 | 2007 | 96 | 0.070 |
Why?
|
| Crack Cocaine | 1 | 2006 | 4 | 0.070 |
Why?
|
| Hospitalization | 3 | 2006 | 417 | 0.070 |
Why?
|
| Schools | 1 | 2006 | 64 | 0.070 |
Why?
|
| Progestins | 1 | 2006 | 18 | 0.070 |
Why?
|
| Regression Analysis | 1 | 2006 | 274 | 0.070 |
Why?
|
| Education, Medical | 1 | 2006 | 67 | 0.070 |
Why?
|
| Sampling Studies | 1 | 2005 | 40 | 0.070 |
Why?
|
| Estradiol Congeners | 1 | 2005 | 2 | 0.070 |
Why?
|
| Animals | 4 | 2012 | 7297 | 0.070 |
Why?
|
| Culture | 1 | 2005 | 38 | 0.070 |
Why?
|
| Research Design | 1 | 2007 | 286 | 0.070 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2007 | 120 | 0.070 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2005 | 43 | 0.070 |
Why?
|
| Testosterone | 1 | 2005 | 47 | 0.070 |
Why?
|
| Anxiety | 1 | 2006 | 159 | 0.070 |
Why?
|
| Child Behavior Disorders | 1 | 2005 | 11 | 0.070 |
Why?
|
| Air Pollutants | 1 | 2005 | 20 | 0.060 |
Why?
|
| Cough | 2 | 2020 | 19 | 0.060 |
Why?
|
| Behavior, Animal | 1 | 2007 | 264 | 0.060 |
Why?
|
| Attitude of Health Personnel | 1 | 2006 | 162 | 0.060 |
Why?
|
| Students, Medical | 1 | 2006 | 121 | 0.060 |
Why?
|
| Mexico | 2 | 2015 | 63 | 0.060 |
Why?
|
| Picornaviridae Infections | 1 | 2004 | 4 | 0.060 |
Why?
|
| Staphylococcus | 1 | 2004 | 6 | 0.060 |
Why?
|
| Child Behavior | 1 | 2004 | 26 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 145 | 0.060 |
Why?
|
| Religion | 2 | 2014 | 30 | 0.060 |
Why?
|
| Cross Infection | 1 | 2004 | 46 | 0.060 |
Why?
|
| Infant | 2 | 2016 | 969 | 0.060 |
Why?
|
| Adolescent Health Services | 1 | 2003 | 11 | 0.060 |
Why?
|
| Mental Health Services | 1 | 2003 | 24 | 0.060 |
Why?
|
| Aftercare | 1 | 2003 | 28 | 0.060 |
Why?
|
| Patient Dropouts | 1 | 2002 | 24 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2022 | 49 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 3717 | 0.050 |
Why?
|
| Severity of Illness Index | 4 | 2007 | 863 | 0.050 |
Why?
|
| Aged | 6 | 2019 | 9487 | 0.050 |
Why?
|
| Telecommunications | 1 | 2001 | 5 | 0.050 |
Why?
|
| Adolescent Development | 1 | 2020 | 2 | 0.050 |
Why?
|
| Emotions | 1 | 2021 | 48 | 0.050 |
Why?
|
| Interleukin-6 | 3 | 2006 | 225 | 0.050 |
Why?
|
| Sex Distribution | 2 | 2015 | 186 | 0.050 |
Why?
|
| Antisocial Personality Disorder | 1 | 2020 | 2 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2022 | 176 | 0.050 |
Why?
|
| Demography | 3 | 2009 | 104 | 0.050 |
Why?
|
| Dizziness | 1 | 2020 | 11 | 0.050 |
Why?
|
| United States Food and Drug Administration | 1 | 2020 | 44 | 0.050 |
Why?
|
| Mental Recall | 1 | 2020 | 52 | 0.050 |
Why?
|
| Dyspnea | 1 | 2020 | 30 | 0.050 |
Why?
|
| Serologic Tests | 1 | 2019 | 10 | 0.050 |
Why?
|
| Bisexuality | 1 | 2019 | 14 | 0.040 |
Why?
|
| Electroconvulsive Therapy | 1 | 1999 | 25 | 0.040 |
Why?
|
| Headache | 1 | 2020 | 74 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2015 | 859 | 0.040 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2018 | 24 | 0.040 |
Why?
|
| Telephone | 1 | 2019 | 48 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2014 | 637 | 0.040 |
Why?
|
| Social Class | 1 | 2018 | 78 | 0.040 |
Why?
|
| Health Behavior | 1 | 2019 | 214 | 0.040 |
Why?
|
| Prognosis | 2 | 2018 | 1362 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 222 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2006 | 464 | 0.040 |
Why?
|
| Phenotype | 1 | 2019 | 629 | 0.040 |
Why?
|
| Feeding Behavior | 1 | 2019 | 159 | 0.040 |
Why?
|
| Sneezing | 2 | 2007 | 6 | 0.040 |
Why?
|
| Disease Progression | 1 | 2019 | 572 | 0.040 |
Why?
|
| Continental Population Groups | 1 | 2018 | 221 | 0.040 |
Why?
|
| Aging | 2 | 2002 | 881 | 0.040 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2007 | 25 | 0.040 |
Why?
|
| Macaca mulatta | 2 | 2007 | 322 | 0.030 |
Why?
|
| Age Distribution | 1 | 2015 | 198 | 0.030 |
Why?
|
| Public Policy | 1 | 2015 | 34 | 0.030 |
Why?
|
| Emigration and Immigration | 1 | 2015 | 32 | 0.030 |
Why?
|
| State Government | 1 | 2014 | 31 | 0.030 |
Why?
|
| Southeastern United States | 1 | 2014 | 71 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2015 | 46 | 0.030 |
Why?
|
| Tobacco Industry | 1 | 2014 | 16 | 0.030 |
Why?
|
| Acculturation | 1 | 2014 | 16 | 0.030 |
Why?
|
| Personality | 1 | 2014 | 16 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2014 | 39 | 0.030 |
Why?
|
| Tablets | 1 | 2013 | 10 | 0.030 |
Why?
|
| Linear Models | 2 | 2006 | 426 | 0.030 |
Why?
|
| Progesterone Congeners | 2 | 2004 | 15 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2014 | 148 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2013 | 169 | 0.030 |
Why?
|
| Incidence | 1 | 2015 | 1119 | 0.030 |
Why?
|
| Communicable Disease Control | 1 | 2007 | 12 | 0.020 |
Why?
|
| Particulate Matter | 1 | 2007 | 30 | 0.020 |
Why?
|
| Haloperidol | 1 | 2007 | 5 | 0.020 |
Why?
|
| Quinpirole | 1 | 2007 | 15 | 0.020 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2006 | 5 | 0.020 |
Why?
|
| Intention | 1 | 2006 | 27 | 0.020 |
Why?
|
| Empathy | 1 | 2006 | 17 | 0.020 |
Why?
|
| Schools, Medical | 1 | 2006 | 42 | 0.020 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2007 | 80 | 0.020 |
Why?
|
| Models, Psychological | 1 | 2005 | 22 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2005 | 41 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2006 | 168 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2013 | 3111 | 0.020 |
Why?
|
| Atmosphere Exposure Chambers | 1 | 2005 | 3 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2005 | 33 | 0.020 |
Why?
|
| Reference Values | 1 | 2005 | 224 | 0.020 |
Why?
|
| Hormone Replacement Therapy | 1 | 2005 | 86 | 0.020 |
Why?
|
| Physical Fitness | 1 | 2006 | 119 | 0.020 |
Why?
|
| Curriculum | 1 | 2006 | 196 | 0.020 |
Why?
|
| Coagulase | 1 | 2004 | 3 | 0.020 |
Why?
|
| Ribotyping | 1 | 2004 | 3 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2004 | 17 | 0.020 |
Why?
|
| Methicillin Resistance | 1 | 2004 | 13 | 0.020 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2004 | 38 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2005 | 501 | 0.020 |
Why?
|
| Hospitals, Psychiatric | 1 | 2003 | 2 | 0.010 |
Why?
|
| Risk | 1 | 2004 | 289 | 0.010 |
Why?
|
| Estrogens | 1 | 2004 | 162 | 0.010 |
Why?
|
| Utilization Review | 1 | 2003 | 16 | 0.010 |
Why?
|
| Skin | 1 | 2005 | 203 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 980 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2006 | 865 | 0.010 |
Why?
|
| Forecasting | 1 | 2003 | 133 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2003 | 246 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 787 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2003 | 440 | 0.010 |
Why?
|
| Walking | 1 | 2002 | 177 | 0.010 |
Why?
|
| Rats | 1 | 2004 | 1604 | 0.010 |
Why?
|
| Affect | 1 | 1999 | 63 | 0.010 |
Why?
|
| Geriatric Assessment | 1 | 2001 | 355 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 1013 | 0.010 |
Why?
|
| Patient Selection | 1 | 1999 | 257 | 0.010 |
Why?
|
| Weight Loss | 1 | 1999 | 413 | 0.010 |
Why?
|